Literature DB >> 32720934

Current and Future Research Into the Mechanism of Action of Regorafenib.

Takayuki Yoshino1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 32720934

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN： 1543-0790


× No keyword cloud information.
  1 in total

1.  Synergistic Anti-Angiogenic Effect of Combined VEGFR Kinase Inhibitors, Lenvatinib, and Regorafenib: A Therapeutic Potential for Breast Cancer.

Authors:  Khuloud Bajbouj; Rizwan Qaisar; Mohammed A Alshura; Zeinab Ibrahim; Mohamad B Alebaji; Amenah W Al Ani; Hanadi M Janajrah; Mariah M Bilalaga; Abdelrahman I Omara; Rebal S Abou Assaleh; Maha M Saber-Ayad; Adel B Elmoselhi
Journal:  Int J Mol Sci       Date:  2022-04-16       Impact factor: 6.208
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.